DE69911579D1 - Antimikrobielle peptide - Google Patents

Antimikrobielle peptide

Info

Publication number: DE69911579D1
Authority: DE; Germany
Prior art keywords: antimicrobial peptides; antimicrobial; peptides
Prior art date: 1998-01-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE69911579T

Other languages

English (en)

Other versions

DE69911579T2 (de

Inventor

Sun-Chang Kim

Chan-Bae Park

Jae-Hyun Lee

Seung-Suh Hong

Hyun-Soo Lee

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Korea Advanced Institute of Science and Technology KAIST

Samyang Genex Corp

Original Assignee

Korea Advanced Institute of Science and Technology KAIST

Samyang Genex Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-22

Filing date

1999-01-22

Publication date

2003-10-30

1999-01-22 Application filed by Korea Advanced Institute of Science and Technology KAIST, Samyang Genex Corp filed Critical Korea Advanced Institute of Science and Technology KAIST

2003-10-30 Publication of DE69911579D1 publication Critical patent/DE69911579D1/de

2004-06-24 Application granted granted Critical

2004-06-24 Publication of DE69911579T2 publication Critical patent/DE69911579T2/de

2019-01-23 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/463—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from amphibians
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Animal Behavior & Ethology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DE69911579T 1998-01-22 1999-01-22 Antimikrobielle peptide Expired - Lifetime DE69911579T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
KR19980001797		1998-01-22
KR9801797		1998-01-22
PCT/KR1999/000036 WO1999037664A1 (en)	1998-01-22	1999-01-22	Novel peptides having biological activity

Publications (2)

Publication Number	Publication Date
DE69911579D1 true DE69911579D1 (de)	2003-10-30
DE69911579T2 DE69911579T2 (de)	2004-06-24

Family

ID=19531909

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69911579T Expired - Lifetime DE69911579T2 (de)	1998-01-22	1999-01-22	Antimikrobielle peptide

Country Status (8)

Country	Link
US (1)	US6531446B1 (de)
EP (1)	EP1049709B1 (de)
JP (1)	JP2002501079A (de)
KR (1)	KR100314721B1 (de)
CN (1)	CN1161372C (de)
CA (1)	CA2318398C (de)
DE (1)	DE69911579T2 (de)
WO (1)	WO1999037664A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2003502023A (ja) *	1999-05-14	2003-01-21	ユーエスアーミーメディカルリサーチアンドマテリアルコマンド	ボツリヌス菌毒素ｂ及び破傷風菌神経毒素の特異的阻害剤及び治療薬としてのブフォリンｉ
US7235521B1 (en)	1999-05-17	2007-06-26	United States Of America As Represented By The Secretary Of The Army	Previns as specific inhibitors and therapeutic agents for botulinum toxin B and tetanus neurotoxins
US6573244B1 (en) *	1999-05-17	2003-06-03	The United States Of America As Represented By The Secretary Of The Army	Previns as specific inhibitors and therapeutic agents for Botulinum toxin B and Tetanus neurotoxins
WO2001081370A2 (en) *	2000-04-24	2001-11-01	Novartis Ag	Histone h2a-derived peptides useful in gene delivery
KR20020051124A (ko) *	2000-12-22	2002-06-28	이한웅	부포린 유도체를 포함하는 함암제
FR2818981A1 (fr) *	2001-01-03	2002-07-05	Synt Em	Peptides amphipathiques et leur utilisation pour le transfert de substances d'interet dans les cellules
KR100441402B1 (ko) *	2002-03-26	2004-07-23	한국과학기술원	항균 활성을 갖는 펩타이드, 이들의 유도체 및 이들을포함하는 항균 조성물
CN1269837C (zh) *	2002-09-02	2006-08-16	上海高科联合生物技术研发有限公司	一组合成抗菌肽
US7091185B2 (en) *	2003-02-24	2006-08-15	Dow Global Technologies Inc.	Periodic antimicrobial peptides
GB0404374D0 (en)	2004-02-27	2004-03-31	Univ Manchester	Treatment of bacterial infections
GB0513096D0 (en)	2005-06-28	2005-08-03	Strathclyde	Treatment of microbial infections
KR100958095B1 (ko)	2007-12-31	2010-05-14	한국과학기술원	번역 동반 시스템을 이용한 항균 펩타이드의 대량 발현방법
JP2010154842A (ja) *	2008-12-03	2010-07-15	Koji Kawakami	Ｅｇｆｒを標的にした新規抗がんキメラペプチド
CN106632685A (zh)	2011-08-10	2017-05-10	韩国科学技术院	具有增加的脂肪酶活性的两亲性肽‑脂肪酶缀合物及其用途
US10856546B2 (en)	2014-10-01	2020-12-08	Plant Health Care, Inc.	Hypersensitive response elicitor peptides and use thereof
JP2017532981A (ja)	2014-10-01	2017-11-09	プラントヘルスケアインコーポレイテッド	破壊された過敏感反応ボックスを有するエリシターペプチド及びその使用
EP3351553A4 (de) *	2015-09-17	2019-06-19	Seoul National University R & DB Foundation	Gebrochenes oder gefaltetes helixförmiges peptid oder peptid-analog mit antimikrobieller aktivität gegen gram-negative bakterien und verwendung davon
CN109069578A (zh)	2016-02-29	2018-12-21	达纳-法伯癌症研究所股份有限公司	用于治疗感染的钉合的细胞内靶向抗微生物肽
EP3439682B1 (de)	2016-04-06	2025-08-13	Plant Health Care, Inc.	Von hypersensiblen reaktionsauslösern abgeleitete peptide und deren verwendung
BR112018069945A2 (pt)	2016-04-06	2019-02-05	Plant Health Care Inc	micróbios benéficos para distribuição de peptídeos ou proteínas efetoras e uso dos mesmos
US11325955B2 (en)	2017-07-19	2022-05-10	Dana-Farber Cancer Institute, Inc.	Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections
CN110256573A (zh) *	2019-05-08	2019-09-20	吉林农业大学	一种杂合抗菌肽bm16r及其制备方法和应用
CN110305193B (zh) *	2019-07-18	2021-10-08	河南科技大学	一种抗牙龈卟啉单胞菌多肽及应用
CN112679594B (zh) *	2020-12-29	2022-03-25	潍坊医学院	一种抗菌肽Buforin IIB的改造体镇痛肽BRL及其应用
WO2022262942A1 (en)	2021-06-15	2022-12-22	Panvir Therapeutics	Anti-tumour peptides
CN114605517B (zh) *	2022-05-12	2022-09-27	广东海洋大学	一种具有广谱抗癌作用的多肽lxp-7及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5177189A (en) *	1989-08-18	1993-01-05	The Scripps Research Institute	Polypeptide analogs of Apolipoprotein E
WO1995019370A1 (en) *	1994-01-18	1995-07-20	Magainin Pharmaceuticals Inc.	Ion-channel forming amphiphilic peptides having n-terminal modifications
FR2715847B1 (fr) *	1994-02-08	1996-04-12	Rhone Poulenc Rorer Sa	Composition contenant des acides nucléiques, préparation et utilisations.
GB9504761D0 (en) *	1995-03-09	1995-04-26	Unilever Plc	Amphiphilic peptide and analogs thereof
US5994306A (en) *	1995-11-22	1999-11-30	Intrabiotics Pharmaceuticals, Inc.	Fine-tuned protegrins
US5981221A (en) *	1997-03-26	1999-11-09	Incyte Pharmaceuticals, Inc.	Histone fusion protein

1999
- 1999-01-21 KR KR1019990001813A patent/KR100314721B1/ko not_active Expired - Fee Related
- 1999-01-22 WO PCT/KR1999/000036 patent/WO1999037664A1/en active IP Right Grant
- 1999-01-22 DE DE69911579T patent/DE69911579T2/de not_active Expired - Lifetime
- 1999-01-22 US US09/600,710 patent/US6531446B1/en not_active Expired - Lifetime
- 1999-01-22 CN CNB998035041A patent/CN1161372C/zh not_active Expired - Fee Related
- 1999-01-22 CA CA002318398A patent/CA2318398C/en not_active Expired - Fee Related
- 1999-01-22 EP EP99900698A patent/EP1049709B1/de not_active Expired - Lifetime
- 1999-01-22 JP JP2000528585A patent/JP2002501079A/ja active Pending

Also Published As

Publication number	Publication date
EP1049709B1 (de)	2003-09-24
JP2002501079A (ja)	2002-01-15
EP1049709A1 (de)	2000-11-08
CA2318398A1 (en)	1999-07-29
DE69911579T2 (de)	2004-06-24
KR100314721B1 (ko)	2001-11-23
CN1161372C (zh)	2004-08-11
CN1291991A (zh)	2001-04-18
US6531446B1 (en)	2003-03-11
CA2318398C (en)	2007-11-13
KR19990068053A (ko)	1999-08-25
WO1999037664A1 (en)	1999-07-29

Publication	Publication Date	Title
DE69911579D1 (de)	2003-10-30	Antimikrobielle peptide
NO982097D0 (no)	1998-05-08	Peptider
NO982098D0 (no)	1998-05-08	Peptider
NO986208L (no)	1998-12-30	Vandige peptidformuleringer
DE69920011D1 (de)	2004-10-14	Rekombinanter venezolanische-equine-pferdeenzephalitis-virusimpstoff
DK1042359T3 (da)	2005-11-28	k-Opioidreceptorpeptider
EP1402001A4 (de)	2006-05-24	Antimikrobielle peptide und zusammensetzungen
NO20005890L (no)	2001-01-12	Antiangiogene peptidmedikamenter
EP1056465A4 (de)	2004-05-26	Antimikrobielle peptide und abgeleitete metapeptide
NO985680D0 (no)	1998-12-04	Peptidderivater
NO983849D0 (no)	1998-08-21	Peptidderivater
EP1173467A4 (de)	2005-12-28	Von chemokinen abgeleitete synthetische peptide
DE69931010D1 (de)	2006-06-01	Peptide mit osteogener Aktivität
DE69931382D1 (de)	2006-06-22	Intein vermittelte peptidligation
DE50009946D1 (de)	2005-05-04	Schädlingsbekämpfungsmittel/depsipeptide
DE69836500D1 (de)	2007-01-04	Antifungale und antibakterielle peptide
FR2791348B1 (fr)	2007-10-05	POLYPEPTIDE Npt2B
ATE295417T1 (de)	2005-05-15	Angiostatin-bindendes protein
EP1181031A4 (de)	2005-07-20	Anti-angiogene peptide
EP1159288A4 (de)	2005-06-01	Alpha-conotoxin-peptide
EP1359930A4 (de)	2004-07-14	Novispirine: antimikrobielle peptide
EP1246834A4 (de)	2004-06-30	Epididymale antimikrobielle peptide
ATE235511T1 (de)	2003-04-15	Vielfältig verzweigte peptidkonstruktionen
NO20012283D0 (no)	2001-05-09	Koblede peptider
NO20013933D0 (no)	2001-08-13	Peptider

Legal Events

Date	Code	Title	Description
2004-10-21	8364	No opposition during term of opposition